Vanguard Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$89.4M Buy
2,687,851
+6,006
+0.2% +$210K ﹤0.01% 1585
2026
Q2
$100M Buy
2,681,845
+49,529
+2% +$1.5M ﹤0.01% 1555
2026
Q1
$89.1M Hold
2,632,316
– – ﹤0.01% 1535

Other funds holding AGIO

Vanguard Capital Management's AGIO Position: Q3 2026 in Review

Vanguard Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 0.22% in Q3 2026, buying an estimated $210K and bringing the position to 2,687,851 shares worth $89.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

Vanguard Capital Management first reported a position in AGIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $100M in Q2 2026. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Vanguard Capital Management held 2,687,851 shares of Agios Pharmaceuticals worth $89.4M as of Q3 2026.
  • Vanguard Capital Management bought 6,006 Agios Pharmaceuticals shares in Q3 2026, an estimated $210K.
  • Agios Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1585 holding.
  • Vanguard Capital Management first reported a position in Agios Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Agios Pharmaceuticals position peaked at $100M in Q2 2026.
  • 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.